Eyebright Medical (China) Top Management
688050 Stock | 89.09 0.66 0.74% |
Eyebright Medical employs about 2.1 K people. The company is managed by 4 executives with a total tenure of roughly 4840 years, averaging almost 1210.0 years of service per executive, having 518.5 employees per reported executive. Analysis of Eyebright Medical's management performance can provide insight into the company performance.
Jiangbing Xie Chairman GM Chairman |
Eyebright |
Eyebright Medical Management Team Effectiveness
The company has return on total asset (ROA) of 0.0872 % which means that it generated a profit of $0.0872 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1476 %, meaning that it generated $0.1476 on every $100 dollars invested by stockholders. Eyebright Medical's management efficiency ratios could be used to measure how well Eyebright Medical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Eyebright Medical's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 2.1 B, whereas Non Currrent Assets Other are forecasted to decline to about 107 M.Eyebright Medical Quarterly Income Before Tax |
|
Eyebright Medical Workforce Comparison
Eyebright Medical Technology is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 2.75 Million. Eyebright Medical adds roughly 2,074 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of 0.27 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.33 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.33. Eyebright Medical Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Eyebright Medical Price Series Summation is a cross summation of Eyebright Medical price series and its benchmark/peer.
Eyebright Medical Notable Stakeholders
An Eyebright Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Eyebright Medical often face trade-offs trying to please all of them. Eyebright Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Eyebright Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Jiangbing Xie | GM Chairman | Profile | |
Baoshan Jia | Deputy Director | Profile | |
Yuqian Zhou | Assistant Secretary | Profile | |
Zhao Wang | RD GM | Profile |
About Eyebright Medical Management Performance
The success or failure of an entity such as Eyebright Medical often depends on how effective the management is. Eyebright Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Eyebright management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Eyebright management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Eyebright Medical is entity of China. It is traded as Stock on SHG exchange.
Please note, the presentation of Eyebright Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Eyebright Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Eyebright Medical's management manipulating its earnings.
Eyebright Medical Workforce Analysis
Traditionally, organizations such as Eyebright Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Eyebright Medical within its industry.Eyebright Medical Manpower Efficiency
Return on Eyebright Medical Manpower
Revenue Per Employee | 458.6K | |
Revenue Per Executive | 237.8M | |
Net Income Per Employee | 146.8K | |
Net Income Per Executive | 76.1M | |
Working Capital Per Employee | 311K | |
Working Capital Per Executive | 161.3M |
Complementary Tools for Eyebright Stock analysis
When running Eyebright Medical's price analysis, check to measure Eyebright Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eyebright Medical is operating at the current time. Most of Eyebright Medical's value examination focuses on studying past and present price action to predict the probability of Eyebright Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eyebright Medical's price. Additionally, you may evaluate how the addition of Eyebright Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |